Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shudo

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
A receptor model for tumor promoters: rational superposition of teleocidins and phorbol estersA Itai, Y Kato, N Tomioka, et al.
European Journal of Biochemistry|January 5, 1999
Purification and cDNA cloning of cytokinin-specific binding protein from mung bean (Vigna radiata)Y Fujimoto, R Nagata, H Fukasawa, et al.
Acta Pharmacologica Sinica|August 15, 2001
Effect of selective IL-6 inhibitor Am-80 on experimental autoimmune encephalomyelitis in DA ratsT Wang, H Nagai, K Bouda, et al.
Japanese Journal of Cancer Research : Gann|June 1, 1987
Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promotersM Hirota, M Suganuma, S Yoshizawa, et al.
Cancer Detection and Prevention|January 1, 1995
Differentiation and tumor response to retinobenzoic acid RE-80 in a malignant conversion modelM F Kulesz-Martin, B Lisafeld, J Paterson, et al.
Biological & Pharmaceutical Bulletin|January 1, 1997
Photoaffinity labeling of tumor promoter-binding protein (CN-TPBP) and preparation of affinity sorbent gelsA Azuma, Y Ando, S Iwasaki, et al.
British Journal of Haematology|April 1, 1997
Re-induction of complete remission with a new synthetic retinoid, Am-80, for relapse of acute promyelocytic leukaemia previously treated with all-trans retinoic acidM Takeuchi, T Yano, E Omoto, et al.
Journal of Medicinal Chemistry|May 23, 1998
Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulationY Endo, S Takehana, M Ohno, et al.
Journal of Medicinal Chemistry|January 22, 1998
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimersH Umemiya, H Fukasawa, M Ebisawa, et al.
Leukemia|April 22, 2005
Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesisT Sanda, T Kuwano, S Nakao, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
A receptor model for tumor promoters: rational superposition of teleocidins and phorbol estersA Itai, Y Kato, N Tomioka, et al.
European Journal of Biochemistry|January 5, 1999
Purification and cDNA cloning of cytokinin-specific binding protein from mung bean (Vigna radiata)Y Fujimoto, R Nagata, H Fukasawa, et al.
Acta Pharmacologica Sinica|August 15, 2001
Effect of selective IL-6 inhibitor Am-80 on experimental autoimmune encephalomyelitis in DA ratsT Wang, H Nagai, K Bouda, et al.
Japanese Journal of Cancer Research : Gann|June 1, 1987
Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promotersM Hirota, M Suganuma, S Yoshizawa, et al.
Cancer Detection and Prevention|January 1, 1995
Differentiation and tumor response to retinobenzoic acid RE-80 in a malignant conversion modelM F Kulesz-Martin, B Lisafeld, J Paterson, et al.
Biological & Pharmaceutical Bulletin|January 1, 1997
Photoaffinity labeling of tumor promoter-binding protein (CN-TPBP) and preparation of affinity sorbent gelsA Azuma, Y Ando, S Iwasaki, et al.
British Journal of Haematology|April 1, 1997
Re-induction of complete remission with a new synthetic retinoid, Am-80, for relapse of acute promyelocytic leukaemia previously treated with all-trans retinoic acidM Takeuchi, T Yano, E Omoto, et al.
Journal of Medicinal Chemistry|May 23, 1998
Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulationY Endo, S Takehana, M Ohno, et al.
Journal of Medicinal Chemistry|January 22, 1998
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimersH Umemiya, H Fukasawa, M Ebisawa, et al.
Leukemia|April 22, 2005
Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesisT Sanda, T Kuwano, S Nakao, et al.
Pageof 16